posted
true but considering the price appreciation this week and the usual Friday profit taking. We did end up with a little green Posts: 2049 | From: Jax,FL,USA | Registered: Nov 2003
| IP: Logged |
posted
cusip change is expected by the end of april, should be in play all month, expect more volatilty as pressure continues with more shakes, often a cusip change by itself does not neccessarily move a stock , but with a low float and outstanding share count along with other news it could really get this going
would love to see a squeeze before the cusip change takes place, then it could go nuts
posted
Pharm Control Ltd.: Pharm Control Ltd. Shareholder Update
Apr 05, 2007 (M2 PRESSWIRE via COMTEX) -- Pharm Control Ltd. (Other OTC: PMCL.PK) is announcing its plan to change the Company's name to Natural Medications Inc. The new Corporate name is a better reflection of the Company's mandate of researching and developing non-synthetic medicines.
Management also wishes to advise its shareholders that all existing shares will be exchanged on a one existing share for one new share basis (1 for 1) once the Name Change has been confirmed and the new CUSIP number has been obtained.
It is management's hope that these initiatives taken will combat the recent short selling of the Company's shares.
About Pharm Control Ltd.
Pharm Control Ltd. is a leading medicine Research and Development company that is devoted to developing medicines that allow patients to live longer, healthier, and more productive lives. The Company's founders have invested over 10 years of research discovering and developing new and effective non-synthetic medicines to fight disorders and sickness in the modern world.
Safe Harbor Statement
The preceding includes forward-looking statements, which involve known and unknown risks, and uncertainties, which may cause the company's actual results in future periods to differ materially from forecasted results. Any forward-looking statements above are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially due to a variety of factors, including, without limitation, competition, intellectual property rights, litigation, needs of liquidity, and other risks detailed from time to time in the company's reports filed with the SEC. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, but not limited to, continued acceptance of the company's products and services, competition, new products and technological changes, as well as any and all "other risks" associated with business.
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info*m2.com.
quote:Originally posted by ohio_trader: Pharm Control Ltd.: Pharm Control Ltd. Shareholder Update
Apr 05, 2007 (M2 PRESSWIRE via COMTEX) -- Pharm Control Ltd. (Other OTC: PMCL.PK) is announcing its plan to change the Company's name to Natural Medications Inc. The new Corporate name is a better reflection of the Company's mandate of researching and developing non-synthetic medicines.
Management also wishes to advise its shareholders that all existing shares will be exchanged on a one existing share for one new share basis (1 for 1) once the Name Change has been confirmed and the new CUSIP number has been obtained.
It is management's hope that these initiatives taken will combat the recent short selling of the Company's shares.
About Pharm Control Ltd.
Pharm Control Ltd. is a leading medicine Research and Development company that is devoted to developing medicines that allow patients to live longer, healthier, and more productive lives. The Company's founders have invested over 10 years of research discovering and developing new and effective non-synthetic medicines to fight disorders and sickness in the modern world.
Safe Harbor Statement
The preceding includes forward-looking statements, which involve known and unknown risks, and uncertainties, which may cause the company's actual results in future periods to differ materially from forecasted results. Any forward-looking statements above are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially due to a variety of factors, including, without limitation, competition, intellectual property rights, litigation, needs of liquidity, and other risks detailed from time to time in the company's reports filed with the SEC. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, but not limited to, continued acceptance of the company's products and services, competition, new products and technological changes, as well as any and all "other risks" associated with business.
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info*m2.com.
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Smile]](smile.gif)
![[Big Grin]](biggrin.gif)
![[Eek!]](eek.gif)
![[Wink]](wink.gif)
![[Razz]](tongue.gif)
